Product Code: GVR-2-68038-069-9
Nebulizer Market Growth & Trends:
The global nebulizer market size is expected to reach USD 1.70 billion by 2030, expanding at a CAGR of 5.9%, from 2023 to 2030, according to a new report by Grand View Research Inc., Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to the market growth.
The COVID-19 outbreak has affected millions of people around the globe. Asthma or COPD patients, who were aware regarding the risk of airborne transmission of COVID-19, were hesitant with regard to the use of inhaled medications, which are considered as a potential source of viral transmission and immunosuppression. Though, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Nebulized albuterol was recommended in some parts of the U.S. as an alternative to albuterol rescue inhalers when pharmacies faced shortage of albuterol inhalers.
COVID-19 affects many elderly people. According to the American Lung Association (ALA) in 2020, nebulized therapy is a safe and effective way to manage COPD at home for patients during COVID-19. Consequently, promotes the nebulizers demand.
According to the Population Reference Bureau report, "Aging in the United States", the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.
Increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth. Furthermore, Technological advancements such as drug-device combination is further expected to create newer opportunity in the nebulizer market.
On the other hand, drug loss during nebulization is the major factor restraining the market growth. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss.
Nebulizer Market Report Highlights:
- Jet nebulizer held over 60% market share in 2022 owing to the greater penetration and low cost of the devices.
- Mesh nebulizers is the fastest growing segment with the CAGR of 6.9% due to various benefits including portability, convenience, homecare application and accurate dosage delivery
- COPD dominated the market in 2022. COPD is a major health concern affecting many people across the world. Hence, the demand for nebulizer is rising.
- By end-use, hospitals dominated the market in 2022. These are an integral part of the healthcare industry and are the major revenue source for the entire industry
- North America dominated the nebulizer market by region in 2022. This high share can be attributed to increase in incidence of respiratory diseases, supportive government policies, favourable reimbursement schemes, rise in awareness, and increase use of home care products
Table of Content
Chapter 1 Methodology And Scope
- 1.1 Market Segmentation And Scope
- 1.1.1 Type
- 1.1.2 End-Use
- 1.1.3 Application
- 1.1.4 Regional Scope
- 1.1.5 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.2 Volume Price Analysis (Model 2)
- 1.6.2.1 Approach 2: Volume Price Analysis
- 1.7 List Of Secondary Sources
- 1.8 List Of Primary Sources
- 1.9 Objectives
- 1.9.1 Objective 1
- 1.9.2 Objective 2
- 1.9.3 Objective 3
- 1.9.4 Objective 4
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Outlook
Chapter 3 Nebulizer Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 User Perspective Analysis
- 3.3.1 Market Influencer Analysis
- 3.4 List Of Key End-Users
- 3.5 Regulatory Framework
- 3.5.1 Regulatory Landscape
- 3.6 Technology Overview
- 3.6.1 Nebulizer Timeline Analysis
- 3.7 Market Dynamics
- 3.7.1 Market Driver Analysis
- 3.7.2 Market Restraint Analysis
- 3.8 Nebulizer Analysis Tools: Porter's Five Forces
- 3.8.1 Supplier Power
- 3.8.2 Buyer Power
- 3.8.3 Threat Of Substitutes
- 3.8.4 Threat Of New Entrants
- 3.8.5 Competitive Rivalry
- 3.9 Nebulizer Market- SWOT Analysis, By Factor (Political & Legal, Economic, Social, and Technological)
- 3.9.1 Political Landscape
- 3.9.2 Economic Landscape
- 3.9.3 Social Landscape
- 3.9.4 Technology Landscape
- 3.9.5 Legal Landscape
- 3.10 COVID-19 Impact Analysis
- 3.11 Respiratory Disease Prevalence
Chapter 4 Nebulizer Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 4.1 Definition And Scope
- 4.2 Type Market Share Analysis, 2022 & 2030
- 4.3 Segment Dashboard
- 4.4 Global Nebulizer Market, By Type, 2018 To 2030
- 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 4.5.1 Jet Nebulizer
- 4.5.1.1 Jet Nebulizer Market, 2018 - 2030 (USD Million)
- 4.5.2 Mesh Nebulizer
- 4.5.2.1 Mesh Nebulizer Market, 2018 - 2030 (USD Million)
- 4.5.2.2 Active
- 4.5.2.2.1 Active Nebulizer Market, 2018 - 2030 (USD Million)
- 4.5.2.3 Passive
- 4.5.2.2.1 Passive Nebulizer Market, 2018 - 2030 (USD Million)
- 4.5.3 Ultrasonic Nebulizer
- 4.5.3.1 Ultrasonic Nebulizer Market, 2018 - 2030 (USD Million)
Chapter 5 Nebulizer Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 5.1 Definition And Scope
- 5.2 Application Market Share Analysis, 2022 & 2030
- 5.3 Segment Dashboard
- 5.4 Global Nebulizer Market, By Application, 2018 To 2030
- 5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 5.5.1 COPD
- 5.5.1.1 COPD Market, 2018 - 2030 (USD Million)
- 5.5.2 Cystic Fibrosis
- 5.5.2.1 Cystic Fibrosis Market, 2018 - 2030 (USD Million)
- 5.5.3 Asthma
- 5.5.3.1 Asthma Market, 2018 - 2030 (USD Million)
- 5.5.4 Others
- 5.5.4.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 Nebulizer Market: Segment Analysis, By End-Use, 2018 - 2030 (USD Million)
- 6.1 Definition And Scope
- 6.2 End-Use Market Share Analysis, 2022 & 2030
- 6.3 Segment Dashboard
- 6.4 Global Nebulizer Market, By End-Use, 2018 To 2030
- 6.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 6.5.1 Hospitals And Clinics
- 6.5.1.1 Hospitals And Clinics Market, 2018 - 2030 (USD Million)
- 6.5.2 Emergency Centers
- 6.5.2.1 Emergency Centers Market, 2018 - 2030 (USD Million)
- 6.5.3 Home Healthcare
- 6.5.3.1 Home Healthcare Market, 2018 - 2030 (USD Million)
Chapter 7 Nebulizer Market: Regional Market Analysis, By Type And End-Use, 2018 - 2030 (USD Million)
- 7.1 Regional Market Share Analysis, 2022 & 2030
- 7.2 Regional Market Snapshot
- 7.3 North America
- 7.3.1 SWOT Analysis
- 7.3.1.1 North America Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.3.2 U.S.
- 7.3.2.1 Key Country Dynamics
- 7.3.2.2 Target Disease Prevalence
- 7.3.2.3 Competitive Scenario
- 7.3.2.4 Regulatory Framework
- 7.3.2.5 Reimbursement Scenario
- 7.3.2.6 U.S. Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.3.3 Canada
- 7.3.3.1 Key Country Dynamics
- 7.3.3.2 Target Disease Prevalence
- 7.3.3.3 Competitive Scenario
- 7.3.3.4 Regulatory Framework
- 7.3.3.5 Reimbursement Scenario
- 7.3.3.6 Canada Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4 Europe
- 7.4.1 Swot Analysis
- 7.4.1.1 Europe Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.2 Germany
- 7.4.2.1 Key Country Dynamics
- 7.4.2.2 Target Disease Prevalence
- 7.4.2.3 Competitive Scenario
- 7.4.2.4 Regulatory Framework
- 7.4.2.5 Reimbursement Scenario
- 7.4.2.6 Germany Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.3 UK
- 7.4.3.1 Key Country Dynamics
- 7.4.3.2 Target Disease Prevalence
- 7.4.3.3 Competitive Scenario
- 7.4.3.4 Regulatory Framework
- 7.4.3.5 Reimbursement Scenario
- 7.4.3.6 Uk Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.4 France
- 7.4.4.1 Key Country Dynamics
- 7.4.4.2 Target Disease Prevalence
- 7.4.4.3 Competitive Scenario
- 7.4.4.4 Regulatory Framework
- 7.4.4.5 Reimbursement Scenario
- 7.4.4.6 France Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.5 Spain
- 7.4.5.1 Key Country Dynamics
- 7.4.5.2 Target Disease Prevalence
- 7.4.5.3 Competitive Scenario
- 7.4.5.4 Regulatory Framework
- 7.4.5.5 Reimbursement Scenario
- 7.4.5.6 Spain Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.6 Italy
- 7.4.6.1 Key Country Dynamics
- 7.4.6.2 Target Disease Prevalence
- 7.4.6.3 Competitive Scenario
- 7.4.6.4 Regulatory Framework
- 7.4.6.5 Reimbursement Scenario
- 7.4.6.6 Italy Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5 Asia Pacific
- 7.5.1 Swot Analysis
- 7.5.1.1 Asia Pacific Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.2 China
- 7.5.2.1 Key Country Dynamics
- 7.5.2.2 Target Disease Prevalence
- 7.5.2.3 Competitive Scenario
- 7.5.2.4 Regulatory Framework
- 7.5.2.5 Reimbursement Scenario
- 7.5.2.6 China Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.3 Japan
- 7.5.3.1 Key Country Dynamics
- 7.5.3.2 Target Disease Prevalence
- 7.5.3.3 Competitive Scenario
- 7.5.3.4 Regulatory Framework
- 7.5.3.5 Reimbursement Scenario
- 7.5.3.6 Japan Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.4 India
- 7.5.4.1 Key Country Dynamics
- 7.5.4.2 Target Disease Prevalence
- 7.5.4.3 Competitive Scenario
- 7.5.4.4 Regulatory Framework
- 7.5.4.5 Reimbursement Scenario
- 7.5.4.6 India Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.5 Australia
- 7.5.5.1 Key Country Dynamics
- 7.5.5.2 Target Disease Prevalence
- 7.5.5.3 Competitive Scenario
- 7.5.5.4 Regulatory Framework
- 7.5.5.5 Reimbursement Scenario
- 7.5.5.6 Australia Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.6 South Korea
- 7.5.6.1 Key Country Dynamics
- 7.5.6.2 Target Disease Prevalence
- 7.5.6.3 Competitive Scenario
- 7.5.6.4 Regulatory Framework
- 7.5.6.5 Reimbursement Scenario
- 7.5.6.6 South Korea Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6 Latin America
- 7.6.1 Swot Analysis
- 7.6.1.1 Latin America Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.2 Brazil
- 7.6.2.1 Key Country Dynamics
- 7.6.2.2 Target Disease Prevalence
- 7.6.2.3 Competitive Scenario
- 7.6.2.4 Regulatory Framework
- 7.6.2.5 Reimbursement Scenario
- 7.6.2.6 Brazil Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.3 Argentina
- 7.6.3.1 Key Country Dynamics
- 7.6.3.2 Target Disease Prevalence
- 7.6.3.3 Competitive Scenario
- 7.6.3.4 Regulatory Framework
- 7.6.3.5 Reimbursement Scenario
- 7.6.3.6 Argentina Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.4 Mexico
- 7.6.4.1 Key Country Dynamics
- 7.6.4.2 Target Disease Prevalence
- 7.6.4.3 Competitive Scenario
- 7.6.4.4 Regulatory Framework
- 7.6.4.5 Reimbursement Scenario
- 7.6.4.6 Mexico Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7 MEA
- 7.7.1 Swot Analysis
- 7.7.1.1 Mea Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.2 Saudi Arabia
- 7.7.2.1 Key Country Dynamics
- 7.7.2.2 Target Disease Prevalence
- 7.7.2.3 Competitive Scenario
- 7.7.2.4 Regulatory Framework
- 7.7.2.5 Reimbursement Scenario
- 7.7.2.6 Saudi Arabia Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.3 UAE
- 7.7.3.1 Key Country Dynamics
- 7.7.3.2 Target Disease Prevalence
- 7.7.3.3 Competitive Scenario
- 7.7.3.4 Regulatory Framework
- 7.7.3.5 Reimbursement Scenario
- 7.7.3.6 Uae Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.4 South Africa
- 7.7.4.1 Key Country Dynamics
- 7.7.4.2 Target Disease Prevalence
- 7.7.4.3 Competitive Scenario
- 7.7.4.4 Regulatory Framework
- 7.7.4.5 Reimbursement Scenario
- 7.7.4.6 South Africa Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.5 Kuwait
- 7.7.5.1 Key Country Dynamics
- 7.7.5.2 Target Disease Prevalence
- 7.7.5.3 Competitive Scenario
- 7.7.5.4 Regulatory Framework
- 7.7.5.5 MEA Nebulizer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Nebulizer Market - Competitive Analysis
- 8.1 Participant's Overview
- 8.1.1 Omron Corporation
- 8.1.2 GE Healthcare
- 8.1.3 Koninklijke Philips N.V.
- 8.1.4 Allied Healthcare
- 8.1.5 Vectura Group Plc.
- 8.1.6 PARI Respiratory Equipment, Inc.
- 8.1.7 Aerogen
- 8.1.8 Devilbiss Healthcare LLC
- 8.1.9 Briggs Healthcare
- 8.1.10 Beurer Gmbh
- 8.2 Financial Performance
- 8.3 Strategy Mapping
- 8.3.1 Expansion
- 8.3.2 Acquisition
- 8.3.3 Collaborations
- 8.3.4 Product Launch
- 8.3.5 Partnerships
- 8.3.6 Others
- 8.4 Participant Categorization
- 8.4.1 Market Leaders
- 8.4.2 Innovators
- 8.5 List Of Private Companies